Sagimet Biosciences
IPO
- Headquarters
- San Mateo, California
- Employees
- 11–50
- Founded
- 2006
- Business Model
- B2B
- Website
- sagimet.com
- Total Funding
- $153.5M
- Last Round
- $80.0M Growth EquityFeb 2021
About
A clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account